| pubmed-article:17991331 | pubmed:abstractText | As a member of the inhibitor of apoptosis (IAP) family, Survivin is highly expressed in various cancers, and is considered as an indicator of poor prognosis. This study was to investigate the expression and prognostic value of Survivin in early-stage non-small cell lung cancer (NSCLC). | lld:pubmed |
